JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Home・Elenco Azioni・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Chiusa

SettoreSettore sanitario

28.49 4.74

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

28.12

Massimo

28.74

Metriche Chiave
By Trading Economics
Entrata	-1.8M -21M
Vendite	4.1M 83M
Margine di Profitto	-25.695
Dipendenti	756
EBITDA	4.8M -19M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+72.58% upside

Dividendi
By Dow Jones
Utili prossimi	24 feb 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-292M 1.6B
Apertura precedente	23.75
Chiusura precedente	28.49

Notizie sul Sentiment di mercato

By Acuity

50%

142 / 352 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

52.655 / 56.31 Supporto e resistenza

PROCEPT BioRobotics Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 feb 2026, 09:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

7 feb 2026, 09:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

7 feb 2026, 05:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

7 feb 2026, 02:46 UTC

Acquisizioni, Fusioni, Takeovers

Big Money, High Anxiety -- Barrons.com

6 feb 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

6 feb 2026, 21:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

6 feb 2026, 21:40 UTC

Acquisizioni, Fusioni, Takeovers

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6 feb 2026, 21:22 UTC

Discorsi di Mercato

Mexico's Inflation Seen Accelerating in January -- Market Talk

6 feb 2026, 21:17 UTC

Utili

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6 feb 2026, 21:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

6 feb 2026, 21:14 UTC

Acquisizioni, Fusioni, Takeovers

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6 feb 2026, 21:13 UTC

Utili

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6 feb 2026, 21:13 UTC

Utili

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6 feb 2026, 21:04 UTC

Discorsi di Mercato

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6 feb 2026, 20:34 UTC

Utili

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

6 feb 2026, 20:27 UTC

Utili

These Stocks Are Today's Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More -- Barrons.com

6 feb 2026, 20:24 UTC

Discorsi di Mercato

Oil Futures Settle Higher As U.S.-Iran Talks Get Under Way -- Market Talk

6 feb 2026, 20:20 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Retreat Ahead of Weekend -- Market Talk

6 feb 2026, 19:48 UTC

Utili

Take-Two, Mondelez Get Analyst Attention -- Barrons.com

6 feb 2026, 19:30 UTC

Acquisizioni, Fusioni, Takeovers

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- WSJ

6 feb 2026, 19:30 UTC

Acquisizioni, Fusioni, Takeovers

Justice Department Asking Industry How Netflix or Paramount Deal for Warner Bros. Might Impact Competition, According to Subpoena -- WSJ

6 feb 2026, 19:30 UTC

Acquisizioni, Fusioni, Takeovers

DOJ Asking if Netflix Engaged in 'Exclusionary Conduct' That May Lead to Monopoly, According to Subpoena -- WSJ

6 feb 2026, 19:17 UTC

Discorsi di Mercato

USDA Says Farm Income to Decrease in 2026 -- Market Talk

6 feb 2026, 18:50 UTC

Utili

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6 feb 2026, 18:47 UTC

Discorsi di Mercato

Natural Gas-Infrastructure Operators Take 'Flight to Scale' -- Market Talk

6 feb 2026, 18:34 UTC

Discorsi di Mercato

U.S. Oil Rig Count Rises By 1 to 412 -- Market Talk

6 feb 2026, 17:58 UTC

Utili

Reddit Stock Falls After Strong Earnings. Wall Street Is Debating What's Next. -- Barrons.com

6 feb 2026, 17:52 UTC

Discorsi di Mercato

Utili

Global Equities Roundup: Market Talk

6 feb 2026, 17:52 UTC

Discorsi di Mercato

Utili

Amazon's CapEx Seen as Misunderstood by Investors -- Market Talk

6 feb 2026, 17:20 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

PROCEPT BioRobotics Corp Previsione

Obiettivo di Prezzo

By TipRanks

72.58% in crescita

Previsioni per 12 mesi

Media 49.6 USD 72.58%

Alto 62 USD

Basso 38 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per PROCEPT BioRobotics Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

6 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 6 che hanno fornito valutazioni azionarie a PROCEPT BioRobotics Corp - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

52.655 / 56.31Supporto e resistenza

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

142 / 352 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.